Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$700M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$344M |
| 3 |
NVIDIA
NVDA
|
+$217M |
| 4 |
Emerson Electric
EMR
|
+$177M |
| 5 |
Apple
AAPL
|
+$169M |
Top Sells
| 1 |
Expedia Group
EXPE
|
+$142M |
| 2 |
Wynn Resorts
WYNN
|
+$141M |
| 3 |
Blackrock
BLK
|
+$135M |
| 4 |
Haleon
HLN
|
+$126M |
| 5 |
Intuit
INTU
|
+$116M |
Sector Composition
| 1 | Technology | 30.36% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 9.06% |
| 5 | Industrials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Vanguard Total World Stock ETF
VT
$52.2B
| $13.3M | 0.01% |
113,422
+2,758
| +2% | +$324K |
|
402
Equinor
EQNR
$61.2B
| $13.2M | 0.01% |
557,483
+34,720
| +7% | +$823K |
|
403
Resideo Technologies
REZI
$5.4B
| $13.1M | 0.01% |
568,673
-64
| -0% | -$1.48K |
|
404
AAR Corp
AIR
$2.69B
| $12.9M | 0.01% |
210,342
| – | – |
|
405
Trustmark
TRMK
$2.44B
| $12.9M | 0.01% |
363,537
-34,895
| -9% | -$1.23M |
|
406
Bristol-Myers Squibb
BMY
$96.1B
| $12.7M | 0.01% |
223,877
-2,603
| -1% | -$147K |
|
407
Neurocrine Biosciences
NBIX
$14.3B
| $12.6M | 0.01% |
92,104
+23,834
| +35% | +$3.25M |
|
408
Myriad Genetics
MYGN
$643M
| $12.4M | ﹤0.01% |
905,209
+302,367
| +50% | +$4.15M |
|
409
Associated Banc-Corp
ASB
$4.4B
| $12.2M | ﹤0.01% |
509,000
| – | – |
|
410
Independent Bank
INDB
$3.54B
| $12.1M | ﹤0.01% |
188,385
+69,753
| +59% | +$4.48M |
|
411
Vertex Pharmaceuticals
VRTX
$101B
| $12M | ﹤0.01% |
29,908
+2,886
| +11% | +$1.16M |
|
412
Cisco
CSCO
$266B
| $11.9M | ﹤0.01% |
201,389
+6,333
| +3% | +$375K |
|
413
PotlatchDeltic
PCH
$3.3B
| $11.9M | ﹤0.01% |
302,959
+76,924
| +34% | +$3.02M |
|
414
iShares ESG Aware MSCI USA ETF
ESGU
$14.3B
| $11.8M | ﹤0.01% |
91,793
-3,674
| -4% | -$473K |
|
415
Diodes
DIOD
$2.47B
| $11.5M | ﹤0.01% |
186,489
+16,003
| +9% | +$987K |
|
416
Celldex Therapeutics
CLDX
$1.55B
| $11.4M | ﹤0.01% |
452,497
+78,145
| +21% | +$1.97M |
|
417
United Parcel Service
UPS
$71.5B
| $11.3M | ﹤0.01% |
89,416
-34,654
| -28% | -$4.37M |
|
418
Ultragenyx Pharmaceutical
RARE
$3.04B
| $11.2M | ﹤0.01% |
+265,189
| New | +$11.2M |
|
419
Cooper Companies
COO
$13.7B
| $11.1M | ﹤0.01% |
120,868
+60,637
| +101% | +$5.57M |
|
420
Zurn Elkay Water Solutions
ZWS
$7.82B
| $10.9M | ﹤0.01% |
+293,187
| New | +$10.9M |
|
421
SPDR S&P Capital Markets ETF
KCE
$589M
| $10.8M | ﹤0.01% |
78,557
-14,805
| -16% | -$2.04M |
|
422
Ligand Pharmaceuticals
LGND
$3.22B
| $10.8M | ﹤0.01% |
100,638
+41,064
| +69% | +$4.4M |
|
423
iShares Core MSCI EAFE ETF
IEFA
$152B
| $10.6M | ﹤0.01% |
150,312
-29,907
| -17% | -$2.1M |
|
424
First Interstate BancSystem
FIBK
$3.45B
| $10.4M | ﹤0.01% |
319,090
+90
| +0% | +$2.92K |
|
425
Kaiser Aluminum
KALU
$1.24B
| $10.4M | ﹤0.01% |
147,421
| – | – |
|